Welcome to LookChem.com Sign In|Join Free

CAS

  • or

490-91-5

Post Buying Request

490-91-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

490-91-5 Usage

Description

Thymoquinone is an allergen In different cedar species.

Chemical Properties

orange to brown crystals

Uses

Different sources of media describe the Uses of 490-91-5 differently. You can refer to the following data:
1. Thymoquinone is a phytochemical compound found in the plant Nigella sativa. Thymoquinone has antioxidant effects and has been shown to protect against heart, liver and kidney damage in animal studies, as well as having possible anti-cancer effects. Thymoquinone also has analgesic and anticonvulsant effects in animal models. Thymoquinone is an angiogenesis inhibitor.
2. Thymoquinone is a phytochemical compound found in the plant Nigella sativa. Thymoquinone has antioxidant effects and has been shown to protect against heart, liver and kidney damage in animal studies, as well as having possible anti-cancer effects. Thymoquinone also has analgesic and anticonvulsant effects in animal models. Thymoquinone is an angiogenesis inhibitor. An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Dyes and metabolites.

Contact allergens

Thymoquinone is an allergen in different cedar species, Cupressaceae family, such as incense cedar (Calocedrus decurrens Florin) used for pencils, chests or toys, and western cedar (Thuja plicata Donn.) as used for hard real- izations such as construction or boats.

Anticancer Research

Different sources of media describe the Anticancer Research of 490-91-5 differently. You can refer to the following data:
1. The black cumin (Nigella sativa) that has a long history of medicinal use contains aphytochemical called thymoquinone (2-methyl-5-isopropyl-1,4-benzoquinone)(Padhye et al. 2008; Khan et al. 2011). In the regions of Southeastern Asia, Africa,Arab and the Mediterranean, the black cumin seeds have a notable history in traditionalmedicine practices. In ancient Egypt, Greece and Turkey, black cumin seedswere often used to treat many diseases and ailments (Padhye et al. 2008; Salih et al.2009; Khan et al. 2011; Ahmad et al. 2013). The Nigella sativa plant seeds and oilare used for medicinal purposes, and they are known for their hepatoprotective,renal-protective, antimicrobial, antidiabetic, anticancer, antihypertensive, analgesic,anti-inflammatory, immunomodulatory, spasmolytic, gastro-protective, bronchodilativeand antioxidant activities (Salih et al. 2009; Khan et al. 2011; Ahmad et al.2013). Recently, Barkat et al. (2017) reported that administration of thymoquinoneto MDA-MB-231 acts on cell cycle and inhibits progression from G1 to S phase bytargeting the cell cycle-related proteins such as cyclin D1, cyclin E and p27. It alsoexhibits histone deacetylase (HDAC) inhibitory effects, targets p21 and Maspin andinduces pro-apoptotic gene, Bax, and downregulates anti-apoptotic gene Bcl-2(Barkat et al. 2017).Thymoquinone is the primary bioactive constituent of seed oil of Nigella sativa. It is a chemopreventiveagent and suppresses the proliferation of breast, colorectal, leukemia, osteosarcoma,ovarian, and pancreatic cancer cells. It suppresses TNF-inducedactivationof NF-κB in a time- and dose-dependent manner and the subsequent inhibition ofIκBα kinase activation, IκBα degradation, phosphorylation, p65 nuclear translocation,and phosphorylation. It specifically suppresses the nuclear p65 and recombinantp65 direct binding to DNA. It also downregulates the expression ofNF-κB-regulated antiapoptotic (survivin, IAP1, Bcl-xL, XIAP IAP2, Bcl-2), proliferative(cyclin D1, c-myc, and COX-2), and angiogenic (VEGF and MMP-9) geneproducts. It suppresses the activation of ERK and AKT pathways and blocks in vitroand in vivo angiogenesis (Aggarwal et al. 2008).
2. Thymoquinone acts on cell cycleand inhibits progression from G1 toS phase by targeting the cellcycle-related proteins such as cyclinD1, cyclin E and p27.It also exhibits histone deacetylase(HDAC) inhibitory effects andtargets p21 and Maspin.Induces pro-apoptotic gene, Bax,and downregulates anti-apoptoticgene Bcl-2Barkat et al.(2017)

Check Digit Verification of cas no

The CAS Registry Mumber 490-91-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,9 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 490-91:
(5*4)+(4*9)+(3*0)+(2*9)+(1*1)=75
75 % 10 = 5
So 490-91-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O2/c1-6(2)8-5-9(11)7(3)4-10(8)12/h4-6H,1-3H3

490-91-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (03416)  Thymoquinone  analytical standard

  • 490-91-5

  • 03416-100MG

  • 458.64CNY

  • Detail

490-91-5Synthetic route

3-isopropyl-4,4-dimethoxy-6-methyl-cyclohexa-2,5-dienone
145674-57-3

3-isopropyl-4,4-dimethoxy-6-methyl-cyclohexa-2,5-dienone

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With hydrogenchloride100%
thymol
89-83-8

thymol

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With [N,N'-bis(salicylidene)ethane-1,2-diaminato]cobalt(II); oxygen In N,N-dimethyl-formamide93%
With oxygen; salcomine In N,N-dimethyl-formamide for 9h; Ambient temperature;79%
With perchloric acid; lead dioxide In acetic acid at 25℃;60%
carvacrol
499-75-2

carvacrol

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With oxygen; salcomine In N,N-dimethyl-formamide Ambient temperature;90%
With Oxone In methanol; water at 20℃; for 0.5h; Catalytic behavior; Reagent/catalyst;32%
With sulfuric acid; water Oxydation mit Braunstein;
carvacrol
499-75-2

carvacrol

A

thymoquinone
490-91-5

thymoquinone

B

3-methyl-6-(2-propyl)-1,2-benzoquinone
78617-27-3

3-methyl-6-(2-propyl)-1,2-benzoquinone

C

diphenyldiselenide

diphenyldiselenide

Conditions
ConditionsYield
With benzeneseleninic acid In dichloromethane for 2h; Ambient temperature;A 82%
B 7%
C n/a
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-methyl-6-(2-propyl)-1,2-benzoquinone
78617-27-3

3-methyl-6-(2-propyl)-1,2-benzoquinone

C

diphenyldiselenide

diphenyldiselenide

Conditions
ConditionsYield
With benzeneseleninic acid In dichloromethane for 2h; Ambient temperature;A 75%
B 19%
C n/a
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

2-(4-hydroxy-5-isopropyl-2-methylphenyl)-6-isopropyl-3-methyl-1,4-benzoquinone
98268-32-7

2-(4-hydroxy-5-isopropyl-2-methylphenyl)-6-isopropyl-3-methyl-1,4-benzoquinone

C

3-hydroxy-5,5'-diisopropyl-2,2'-dimethyl-4,4'-diphenoquinone
98268-34-9

3-hydroxy-5,5'-diisopropyl-2,2'-dimethyl-4,4'-diphenoquinone

Conditions
ConditionsYield
With oxygen; copper dichloride In ethanol at 60℃; for 48h; Product distribution; var. solvents;A 25%
B 65%
C 10%
With oxygen; copper dichloride In ethanol at 60℃; for 48h;A 25%
B 65%
C 10%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-hydroxy-5-isopropyl-2-methyl-[1,4]benzoquinone
4586-58-7

3-hydroxy-5-isopropyl-2-methyl-[1,4]benzoquinone

Conditions
ConditionsYield
With phosphomolybdic acid; dihydrogen peroxide In acetic acid at 30℃; for 5h;A 64%
B 13.5 % Chromat.
With phosphomolybdic acid; dihydrogen peroxide In acetic acid at 30℃; for 5h; Further byproducts given;A 64 % Chromat.
B 13.2%
With dihydrogen peroxide; methyltrioxorhenium(VII) In acetic acid at 40℃; for 2h;A 4%
B 8%
carvacrol
499-75-2

carvacrol

A

thymoquinone
490-91-5

thymoquinone

B

thymohydroquinone
2217-60-9

thymohydroquinone

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform for 3h; Ambient temperature;A 50.2%
B 25.5%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

thymohydroquinone
2217-60-9

thymohydroquinone

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform for 3h; Ambient temperature;A 47%
B 30%
With 3-chloro-benzenecarboperoxoic acid In chloroform for 3h; Ambient temperature;A 47%
B 30%
carvacrol
499-75-2

carvacrol

A

thymoquinone
490-91-5

thymoquinone

C10H14O3

C10H14O3

3,10-dihydroxy-6,12-di-iso-propyl-3,10-dimethyltricyclo[6.2.2.02,7]dodeca-5,11-diene-4,9-dione
95475-28-8, 106623-23-8, 113159-72-1

3,10-dihydroxy-6,12-di-iso-propyl-3,10-dimethyltricyclo[6.2.2.02,7]dodeca-5,11-diene-4,9-dione

Conditions
ConditionsYield
With o-iodophenylacetic acid; 3-chloro-benzenecarboperoxoic acid In dichloromethane at 20℃; for 3h; Inert atmosphere;A 37%
B 10%
C 32%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-hydroxy-5,5'-diisopropyl-2,2'-dimethyl-4,4'-diphenoquinone
98268-34-9

3-hydroxy-5,5'-diisopropyl-2,2'-dimethyl-4,4'-diphenoquinone

Conditions
ConditionsYield
With oxygen; copper dichloride In acetonitrile at 60℃; for 48h;A 32%
B 10%
With oxygen; copper dichloride In N,N-dimethyl-formamide at 60℃; for 48h;A 25%
B 30%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-hydroxy-5-isopropyl-2-methyl-[1,4]benzoquinone
4586-58-7

3-hydroxy-5-isopropyl-2-methyl-[1,4]benzoquinone

C

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione
138525-31-2

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione
10476-80-9, 138525-30-1

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione

Conditions
ConditionsYield
With 3,3-dimethyldioxirane; sodium hydrogencarbonate In acetone Further byproducts given;A 23%
B 9%
C 18%
D 12%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-methyl-6-(2-propyl)-1,2-benzoquinone
78617-27-3

3-methyl-6-(2-propyl)-1,2-benzoquinone

C

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione
138525-31-2

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione
10476-80-9, 138525-30-1

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione

Conditions
ConditionsYield
With 3,3-dimethyldioxirane; sodium hydrogencarbonate In acetone Further byproducts given;A 23%
B 9%
C 18%
D 12%
4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform for 3h; Ambient temperature;20.8%
thymol
89-83-8

thymol

A

thymoquinone
490-91-5

thymoquinone

B

3-isopropyl-6-methyl-1,2-benzenediol
490-06-2

3-isopropyl-6-methyl-1,2-benzenediol

C

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione
138525-31-2

2-hydroxy-2-isopropyl-5-methylcyclohex-5-ene-1,4-dione

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione
10476-80-9, 138525-30-1

trans-2-hydroxy-6-isopropyl-3-methylcyclohex-5-ene-1,4-dione

Conditions
ConditionsYield
With 3,3-dimethyldioxirane In acetoneA 10%
B 15 % Spectr.
C 5%
D 5%
ethanol
64-17-5

ethanol

2-isopropyl-5-methyl-[1,4]benzoquinone-4-chlorimin

2-isopropyl-5-methyl-[1,4]benzoquinone-4-chlorimin

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
at 130 - 140℃;
thymohydroquinone
2217-60-9

thymohydroquinone

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With nitric acid
With iron(III) chloride
With p-benzoquinone
durch eine Oxydase, die in den Blaettern von Monarda fistulosa vorkommt;
With 3,3-dimethyldioxirane; sodium hydrogencarbonate In acetone81 % Chromat.
2-isopropyl-5-methyl-p-benzoquinone dioxime
74317-48-9

2-isopropyl-5-methyl-p-benzoquinone dioxime

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With copper(I) oxide; anhydrous methoxyethanol; acetone weiteres Reagens: wss. HCl;
4-aminocarvacrol
117886-49-4

4-aminocarvacrol

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
bei der Oxydation;
4-aminothymol
1128-28-5

4-aminothymol

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With potassium dichromate; sulfuric acid
With Nitrite Diazotization;
With hydrogenchloride; copper(II) sulfate
With chromium(III) oxide; sulfuric acid
2-isopropyl-5-methyl-p-phenylenediamine
4389-60-0

2-isopropyl-5-methyl-p-phenylenediamine

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With iron(III) chloride at 20℃;
1,1-bis(5-isopropyl-4-hydroxy-2-methylphenyl)ethane
120108-97-6

1,1-bis(5-isopropyl-4-hydroxy-2-methylphenyl)ethane

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With manganese(IV) oxide; sulfuric acid
2-isopropyl-5-methyl-[1,4]benzoquinon-4-(4-ethoxy-5-isopropyl-2-methyl-phenylimine)

2-isopropyl-5-methyl-[1,4]benzoquinon-4-(4-ethoxy-5-isopropyl-2-methyl-phenylimine)

A

thymoquinone
490-91-5

thymoquinone

B

4-ethoxy-5-isopropyl-2-methyl-aniline
5665-96-3

4-ethoxy-5-isopropyl-2-methyl-aniline

Conditions
ConditionsYield
With sulfuric acid
4-amino-2-isopropyl-5-methyl-phenol; hydrochloride
6321-11-5

4-amino-2-isopropyl-5-methyl-phenol; hydrochloride

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With chromium(VI) oxide; sulfuric acid; water weiteres Reagens: Essigsaeure;
2-isopropyl-5-methyl-[1,4]benzoquinone-4-chlorimin

2-isopropyl-5-methyl-[1,4]benzoquinone-4-chlorimin

acetic acid
64-19-7

acetic acid

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
at 130 - 140℃;
4-Isopropenyl-2-isopropyl-4-methoxy-cyclobut-2-enone

4-Isopropenyl-2-isopropyl-4-methoxy-cyclobut-2-enone

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate 1.) o-xylene, 100 deg C, 20 min, 2.) CH3CN, H2O, 0.5 h; Yield given. Multistep reaction;
Dithymoquinone anion radical

Dithymoquinone anion radical

A

thymoquinone
490-91-5

thymoquinone

B

Thymoquinone anion radical

Thymoquinone anion radical

Conditions
ConditionsYield
In acetonitrile Rate constant; 0.1 M Bu4NPF6;
(4R,5S)-4-hydroxy-5-isopropyl-2-methyl-2-cyclohexenone

(4R,5S)-4-hydroxy-5-isopropyl-2-methyl-2-cyclohexenone

thymoquinone
490-91-5

thymoquinone

Conditions
ConditionsYield
With manganese(IV) oxide In benzene
2-isopropyl-4,4-dimethoxy-5-methyl-cyclohexa-2,5-dienone
145674-58-4

2-isopropyl-4,4-dimethoxy-5-methyl-cyclohexa-2,5-dienone

A

thymoquinone
490-91-5

thymoquinone

B

2-Chloro-6-isopropyl-4-methoxy-3-methyl-phenol

2-Chloro-6-isopropyl-4-methoxy-3-methyl-phenol

Conditions
ConditionsYield
With hydrogenchloride
2-methyl-5-isopropyl-p-benzosemiquinone

2-methyl-5-isopropyl-p-benzosemiquinone

A

thymoquinone
490-91-5

thymoquinone

B

thymohydroquinone
2217-60-9

thymohydroquinone

Conditions
ConditionsYield
In water at 22℃; Rate constant;
thymoquinone
490-91-5

thymoquinone

Diphenylphosphinic chloride
1499-21-4

Diphenylphosphinic chloride

C22H22ClO3P

C22H22ClO3P

Conditions
ConditionsYield
With aluminum (III) chloride In toluene at 25℃; for 24h;97%
thymoquinone
490-91-5

thymoquinone

cyclopenta-1,3-diene
542-92-7

cyclopenta-1,3-diene

7-isopropyl-4a-methyl-1,4,4a,8a-tetrahydro-1,4-methanonaphthalene-5,8-dione

7-isopropyl-4a-methyl-1,4,4a,8a-tetrahydro-1,4-methanonaphthalene-5,8-dione

Conditions
ConditionsYield
In dichloromethane for 3h; Diels-Alder Cycloaddition; Reflux;96%
With iron(III) chloride In neat (no solvent, solid phase) at 20℃; for 0.333333h; Diels-Alder Cycloaddition;93%
In dichloromethane at 20℃; for 120h; Time; Diels-Alder Cycloaddition; diastereoselective reaction;80%
thymoquinone
490-91-5

thymoquinone

2-isopropyl-5-methyl-[1,4]benzoquinone-4-oxime
17302-61-3

2-isopropyl-5-methyl-[1,4]benzoquinone-4-oxime

Conditions
ConditionsYield
With hydroxylamine hydrochloride In ethanol for 24h; Heating;94%
With hydroxylamine hydrochloride; sodium acetate In ethanol for 1.5h; Reflux;81%
With hydrogenchloride; ethanol; hydroxylamine hydrochloride
thymoquinone
490-91-5

thymoquinone

N-allylphenethylamine
5263-58-1

N-allylphenethylamine

2-((allyl(phenethyl)amino)methyl)-5-isopropylbenzene-1,4-diol

2-((allyl(phenethyl)amino)methyl)-5-isopropylbenzene-1,4-diol

Conditions
ConditionsYield
With triethylamine In isopropyl alcohol at 70℃; for 2h; Inert atmosphere; regioselective reaction;93%
thymoquinone
490-91-5

thymoquinone

triphenylphosphonium trifluoromethanesulfonate
85873-18-3

triphenylphosphonium trifluoromethanesulfonate

2,5-dihydroxy-3-isopropyl-6-methylphenyl(triphenyl)phosphonium trifluoromethanesulfonate

2,5-dihydroxy-3-isopropyl-6-methylphenyl(triphenyl)phosphonium trifluoromethanesulfonate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 24h; Inert atmosphere; regioselective reaction;90%
thymoquinone
490-91-5

thymoquinone

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

2-isopropyl-5-methyl-p-benzoquinone dioxime dimethyl ether

2-isopropyl-5-methyl-p-benzoquinone dioxime dimethyl ether

Conditions
ConditionsYield
In ethanol for 24h; Heating;87%
thymoquinone
490-91-5

thymoquinone

thymohydroquinone
2217-60-9

thymohydroquinone

Conditions
ConditionsYield
With acetic acid; zinc at 20℃; for 4h; Inert atmosphere;83%
With sodium dithionite In methanol; water at 25℃; for 2h; Inert atmosphere;49%
With hydrogenchloride; tin(ll) chloride
thymoquinone
490-91-5

thymoquinone

triphenylphosphonium hydrotrifluoroacetate
142572-85-8

triphenylphosphonium hydrotrifluoroacetate

2,5-dihydroxy-3-isopropyl-6-methylphenyl(triphenyl)phosphonium trifluoroacetate

2,5-dihydroxy-3-isopropyl-6-methylphenyl(triphenyl)phosphonium trifluoroacetate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 24h; Inert atmosphere; regioselective reaction;81%
thymoquinone
490-91-5

thymoquinone

(3-Cyclopropylidenprop-1-enyl)-ethyl-ether
147722-36-9

(3-Cyclopropylidenprop-1-enyl)-ethyl-ether

rac-4'β-Ethoxy-1',4',4'a,5',8',8'a-hexahydro-4'-isopropyl-7'aα-methylspiro-5',8'-dion

rac-4'β-Ethoxy-1',4',4'a,5',8',8'a-hexahydro-4'-isopropyl-7'aα-methylspiro-5',8'-dion

rac-4'β-Ethoxy-1',4',4'a,5',8',8'a-hexahydro-7'-isopropyl-4'aα-methylspiro-5',8'-dion

rac-4'β-Ethoxy-1',4',4'a,5',8',8'a-hexahydro-7'-isopropyl-4'aα-methylspiro-5',8'-dion

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 50℃; for 24h;A 2.8%
B 80.4%
thymoquinone
490-91-5

thymoquinone

(4E)-2-isopropyl-5-methylbenzo-1,4-quinone 4-oxime
914796-82-0

(4E)-2-isopropyl-5-methylbenzo-1,4-quinone 4-oxime

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium acetate In ethanol for 1.5h; Heating;80%
thymoquinone
490-91-5

thymoquinone

4-hydrazino-2-isopropyl-5-methylphenol

4-hydrazino-2-isopropyl-5-methylphenol

Conditions
ConditionsYield
With hydrazine hydrate In ethanol at 90℃; for 2h;78%
thymoquinone
490-91-5

thymoquinone

5,5-dimethoxy-1,2,3,4-tetrachlorocyclopentadiene
2207-27-4

5,5-dimethoxy-1,2,3,4-tetrachlorocyclopentadiene

(+/-)-(1S*,2S*,7R*,8R*)-1,8,9,10-Tetrachlor-5-isopropyl-11,11-dimethoxy-2-methyltricyclo<6.2.1.02,7>undec-4,9-dien-3,6-dion

(+/-)-(1S*,2S*,7R*,8R*)-1,8,9,10-Tetrachlor-5-isopropyl-11,11-dimethoxy-2-methyltricyclo<6.2.1.02,7>undec-4,9-dien-3,6-dion

Conditions
ConditionsYield
In melt at 118℃; for 120h;76%
1,3-dimethylindole
875-30-9

1,3-dimethylindole

thymoquinone
490-91-5

thymoquinone

3-isopropyl-6,10b-dimethyl-5a,6,10b,11-tetrahydrochromeno[2,3-b]indol-2-ol

3-isopropyl-6,10b-dimethyl-5a,6,10b,11-tetrahydrochromeno[2,3-b]indol-2-ol

Conditions
ConditionsYield
With triethylamine In ethanol at 70℃; for 12h;75%
thymoquinone
490-91-5

thymoquinone

bis(trimethylsilyl)carbodi-imide
1000-70-0

bis(trimethylsilyl)carbodi-imide

(E,E)-N,N'-Dicyan-2-isopropyl-5-methyl-1,4-benzochinondiimin
110375-15-0

(E,E)-N,N'-Dicyan-2-isopropyl-5-methyl-1,4-benzochinondiimin

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane for 3h; Ambient temperature;74%
3,3-dimethyl acrylaldehyde
107-86-8

3,3-dimethyl acrylaldehyde

thymoquinone
490-91-5

thymoquinone

C15H18O2
1567408-41-6

C15H18O2

Conditions
ConditionsYield
With (R)-2-(diphenyl(trimethylsilyloxy)methyl)pyrrolidine; o-fluoro-benzoic acid In chloroform-d1 at 40℃; for 24h; enantioselective reaction;74%
thymoquinone
490-91-5

thymoquinone

benzylamine
100-46-9

benzylamine

5-isopropyl-2-methyl-3-(benzylamino)-1,4-benzoquinone

5-isopropyl-2-methyl-3-(benzylamino)-1,4-benzoquinone

Conditions
ConditionsYield
With oxygen In methanol at 20℃; for 72h;73.6%
(2-aminoethyl)morpholine

(2-aminoethyl)morpholine

thymoquinone
490-91-5

thymoquinone

5-isopropyl-2-methyl-3-((2-morpholinoethyl)amino)-1,4-benzoquinone

5-isopropyl-2-methyl-3-((2-morpholinoethyl)amino)-1,4-benzoquinone

Conditions
ConditionsYield
With oxygen In methanol at 20℃; for 48h;68.3%
thymoquinone
490-91-5

thymoquinone

ethanolamine
141-43-5

ethanolamine

5-isopropyl-2-methyl-3-(2-hydroxyethylamino)-1,4-benzoquinone

5-isopropyl-2-methyl-3-(2-hydroxyethylamino)-1,4-benzoquinone

Conditions
ConditionsYield
With oxygen In methanol at 20℃; for 36h;66.7%
2-(1H-pyrrol-1-yl)aniline
6025-60-1

2-(1H-pyrrol-1-yl)aniline

thymoquinone
490-91-5

thymoquinone

5-isopropyl-2-methyl-5'H-spiro[cyclohexa[2,5]diene-1,4'-pyrrolo[1,2-a]quinoxalin]-4-one

5-isopropyl-2-methyl-5'H-spiro[cyclohexa[2,5]diene-1,4'-pyrrolo[1,2-a]quinoxalin]-4-one

Conditions
ConditionsYield
With trifluoroacetic anhydride In tetrahydrofuran at 100℃; Sealed tube; Inert atmosphere;66%
thymoquinone
490-91-5

thymoquinone

3,4-dimethoxybenzylamine
5763-61-1

3,4-dimethoxybenzylamine

5-isopropyl-2-methyl-3-(3,4-dimethoxylbenzylamino)-1,4-benzoquinone

5-isopropyl-2-methyl-3-(3,4-dimethoxylbenzylamino)-1,4-benzoquinone

Conditions
ConditionsYield
With oxygen In methanol at 20℃; for 24h;61.1%
3-Phenylbutyraldehyde
16251-77-7

3-Phenylbutyraldehyde

thymoquinone
490-91-5

thymoquinone

(S)-2-isopropyl-4a-methyl-6-phenyl-4a,5-dihydronaphthalene-1,4-dione

(S)-2-isopropyl-4a-methyl-6-phenyl-4a,5-dihydronaphthalene-1,4-dione

Conditions
ConditionsYield
With α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether; oxygen; palladium diacetate; copper(II) bis(trifluoromethanesulfonate); o-fluoro-benzoic acid In dimethyl sulfoxide at 40℃; for 36h; Schlenk technique; Molecular sieve; enantioselective reaction;54%
thymoquinone
490-91-5

thymoquinone

A

3-azido-2-methyl-5-isopropyl-1,4-benzoquinone

3-azido-2-methyl-5-isopropyl-1,4-benzoquinone

B

thymohydroquinone
2217-60-9

thymohydroquinone

C

3-azido-2-methyl-5-isopropyl-1,4-benzohydroquinone
17414-17-4

3-azido-2-methyl-5-isopropyl-1,4-benzohydroquinone

Conditions
ConditionsYield
With hydrogenchloride; sodium azide In methanol; water for 5h; Ambient temperature;A 14%
B 20%
C 52%
succinic acid
110-15-6

succinic acid

thymoquinone
490-91-5

thymoquinone

3-(2-methyl-5-(1-methylethyl)-3,6-dioxocyclohexa-1,4-dienyl)propanoic acid
1240724-54-2

3-(2-methyl-5-(1-methylethyl)-3,6-dioxocyclohexa-1,4-dienyl)propanoic acid

Conditions
ConditionsYield
With ammonium peroxydisulfate; silver nitrate In water; acetonitrile at 100℃; for 12h;52%
With ammonium peroxydisulfate; silver nitrate In water; acetonitrile
With ammonium persulfate; silver nitrate In water; acetonitrile at 100℃;
With ammonium peroxydisulfate; silver nitrate In water; acetonitrile at 100℃; for 13h;0.22 g

490-91-5Relevant articles and documents

Fe(III) Protoporphyrin IX Encapsulated in a Zinc Metal-Organic Framework Shows Dramatically Enhanced Peroxidatic Activity

Dare, Nicola A.,Brammer, Lee,Bourne, Susan A.,Egan, Timothy J.

, p. 1171 - 1183 (2018)

Two MOFs, [H2N(CH3)2][Zn3(TATB)2(HCOO)]·HN(CH3)2·DMF·6H2O (1) and Zn-HKUST-1 (2), were investigated as potential hosts to encapsulate Fe(III) heme (Fe(III) protoporphyrin IX = Fe(III)PPIX). Methyl orange (MO) adsorption was used as an initial model for substrate uptake. MOF 1 showed good adsorption of MO (10.3 ± 0.8 mg g-1) which could undergo in situ protonation upon exposure to aqueous HCl vapor. By contrast, MO uptake by 2 was much lower (2 ± 1 mg g-1), and PXRD indicated that structural instability on exposure to water was the likely cause. Two methods for Fe(III)PPIX-1 preparation were investigated: soaking and encapsulation. Encapsulation was verified by SEM-EDS and showed comparable concentrations of Fe(III)PPIX on exposed interior surfaces and on the original surface of fractured crystals. SEM-EDS results were consistent with ICP-OES data on bulk material (1.2 ± 0.1 mass % Fe). PXRD data showed that the framework in 1 was unchanged after encapsulation of Fe(III)PPIX. MO adsorption (5.8 ± 1.2 mg g-1) by Fe(III)PPIX-1 confirmed there is space for substrate diffusion into the framework, while the UV-vis spectrum of solubilized crystals confirmed that Fe(III)PPIX retained its integrity. A solid-state UV-vis spectrum of Fe(III)PPIX-1 indicated that Fe(III)PPIX was not in a μ-oxo dimeric form. Although single-crystal XRD data did not allow for full refinement of the encapsulated Fe(III)PPIX molecule owing to disorder of the metalloporphyrin, the Fe atom and pyrrole N atoms were located, enabling rigid-body modeling of the porphine core. Reaction of 2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) with H2O2, catalyzed by Fe(III)PPIX-1 and -2, showed that Fe(III)PPIX-1 is significantly more efficient than Fe(III)PPIX-2 and is superior to solid Fe(III)PPIX-Cl. Fe(III)PPIX-1 was used to catalyze the oxidation of hydroquinone, thymol, benzyl alcohol, and phenyl ethanol by tert-butyl-hydroperoxide with t1/2 values that increase with increasing substrate molecular volume.

Hydrothermal synthesis, crystal structure and heterogeneous catalytic activity of a novel inorganic-organic hybrid complex, possessing infinite La-O-La linkages

Ay, Burak,Yildiz, Emel,Protasiewicz, John D.,Rheingold, Arnold L.

, p. 208 - 213 (2013)

In this paper, a novel lanthanum coordination polymer formulated as {[La2(Hpdc)3(H2O)4]·2H 2O}n (1, H3pdc = 3,5-pyrazoledicarboxylic acid) has been synthesized by the reaction of H3pdc with chloride salt of La(III) under hydrothermal conditions and characterized by elemental analysis, FT-IR, TGA and single-crystal X-ray diffraction. The complex crystallized in the monoclinic system Cc space group. The single-crystal X-ray structural analysis revealed that central metal La atoms are nine-coordinate and linked by bridging μ2-OCOO- groups to form [La(1)- (μ2-OCOO-)2-La(2)]n inorganic-organic chains that produce a supramolecular polymeric framework structure. The three-dimensional structure of 1 is accompanied by non-coordinating water molecules. Thermal behavior and catalytic performance of 1 have also been studied. The complex 1 showed 100% selectivity and a conversion rate of 24% on the oxidation of thymol (T) to thymoquinone (TQ).

Hydrothermal synthesis, structure, heterogeneous catalytic activity and photoluminescent properties of a novel homoleptic Sm(III)-organic framework

Ay, Burak,Yildiz, Emel,Felts, Ashley C.,Abboud, Khalil A.

, p. 61 - 68 (2016)

A novel metal-organic framework, (H2pip)n[Sm2(pydc)4(H2O)2]n (1) (H2pydc=2,6-pyridinedicarboxylic acid, H2pip=piperazine) has been synthesized under hydrothermal conditions and characterized by the elemental analysis, inductively coupled plasma (ICP) spectrometer, fourier transform infrared (FT-IR) spectra, thermogravimetric analysis (TGA), single crystal X-ray diffraction analysis and powder X-ray diffraction (PXRD). The structure of 1 was determined to be three-dimensional, linked along Sm-O-Sm chains. The asymmetric unit consisted of one singly anionic fragment consisting of Sm(III) coordinated to two H2pydc ligands and one water, and one half of a protonated H2pip, which sits on an inversion center. 1 exhibited luminescence emission bands at 534?nm at room temperature when excited at 440?nm. Its thermal behavior and catalytic performance were investigated and the selectivity was measured as 100% for the oxidation of thymol to thymoquinone.

Two novel isostructural and heteroleptic Nd(III) and Dy(III)-organic frameworks constructed by 2,5-pyridinedicarboxylic acid and in situ generated 2-pyridinecarboxylic acid: Hydrothermal synthesis, characterization, photoluminescence properties and heterogeneous catalytic activities

Ay, Burak,Yildiz, Emel,Kani, ?brahim

, p. 165 - 175 (2017)

The crystal structures, heterogeneous catalytic activities and photoluminescent properties of two novel three dimensional (3D) metal organic frameworks (MOFs), [Nd(pyc)(pydc)(H2O)]n (1) and [Dy(pyc)(pydc)(H2O)]n (2) (H2pydc?=?pyridine-2,5-dicarboxylic acid, Hpyc?=?2-pyridinecarboxylic acid) are presented. The synthesized complexes under hydrothermal conditions were characterized by the elemental analysis, inductively coupled plasma (ICP), fourier transform infrared (FT-IR) spectroscopy, thermogravimetric analysis (TGA), single crystal X-ray diffraction and powder X-ray diffraction (PXRD) analysis. For morphological analysis, field emission scanning electron microscopy (FESEM) and atomic force microscopy (AFM) were used. The compounds are isostructural and each Ln3+ (Nd(III) and Dy(III)) centers are eight-coordinated. MOFs have the distinct 3D open-framework architectures due to the presence of Hpyc ligands, which are converted from H2pydc ligands in-situ decarboxylation under the hydrothermal conditions. Photoluminescence properties and thermal stabilities of the compounds have been investigated. Their heterogeneous catalytic activities have also been examined on the oxidation of the thymol (T) to thymoquinone (TQ). The structures of the MOFs were stable after three catalytic cycles. The maximum T conversion values, 40.37% and 36.45% were recorded with nearly 100% selectivities by using 1 and 2, respectively.

PHOTOOXIDATION OF 2,3,6-TRIMETHYLPHENOL

-

Page/Page column 14-15, (2021/11/26)

The present invention relates to the photooxidation of 2,3,6-trimethyl- phenol to yield 2,3,5-trimethylbenzoquinone using methylene blue as photo- sensitizer in a solvent mixture of water and alcohols using light of the high wave- length range of the visible spectrum.

PHOTOOXIDATION OF 2,3,5-TRIMETHYLPHENOL

-

Page/Page column 14-17, (2021/11/26)

The present invention relates to the photooxidation of 2,3,5-trimethyl- phenol to yield 2,3,5-trimethylbenzoquinone using methylene blue as photo- sensitizer in a solvent mixture of water and alcohols using light of the high wavelength range of the visible spectrum.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 490-91-5